{"transactions":[{"id":4624100,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":25446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":37500,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":25446},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624099,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":10406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":18594,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":10406},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624098,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":62946,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624097,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":29000,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624096,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":63346,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624095,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":29400,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624094,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":35852,"price":43.0545,"value":1543589.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624093,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":25446,"price":30.27,"value":770250.42,"ownership":{"direct":true},"balance_after":48967,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624092,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":10406,"price":30.69,"value":319360.14,"ownership":{"direct":true},"balance_after":23521,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624091,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":800,"price":43,"value":34400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624090,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":30.27,"value":12108.0,"ownership":{"direct":true},"balance_after":13915,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624089,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":400,"price":30.69,"value":12276.0,"ownership":{"direct":true},"balance_after":13515,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624088,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":43.0146,"value":77426.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624087,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":30.27,"value":27243.0,"ownership":{"direct":true},"balance_after":14915,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4624086,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:48:12.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":900,"price":30.69,"value":27621.0,"ownership":{"direct":true},"balance_after":14015,"source":{"system":"sec-edgar","filing":"0002009762-26-000006","document":"form4-09182026_080908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000006/form4-09182026_080908.xml","form_type":"4"}},{"id":4613574,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":10754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":64246,"derivative":{"exercise_price":30.27,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":10754},"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613573,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date"}],"balance_after":30300,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613572,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":22954,"price":43.1014,"value":989349.5356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613571,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":10754,"price":30.27,"value":325523.58,"ownership":{"direct":true},"balance_after":36069,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613570,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":12200,"price":30.69,"value":374418.0,"ownership":{"direct":true},"balance_after":25315,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613569,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":42.7947,"value":42794.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613568,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":42.2475,"value":190113.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.59 to $42.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14115,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":4613567,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:12:16.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":41.9839,"value":230911.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.51 to $42.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18615,"source":{"system":"sec-edgar","filing":"0002009762-26-000005","document":"form4-09092026_090911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000005/form4-09092026_090911.xml","form_type":"4"}},{"id":774809,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-19T01:51:38.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 36 equal monthly installments beginning on June 14, 2026."}],"balance_after":21231,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21231},"source":{"system":"sec-edgar","filing":"0001424383-26-000003","document":"form4-05192026_010535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000142438326000003/form4-05192026_010535.xml","form_type":"4"}},{"id":775461,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T20:18:54.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0002063957-26-000001","document":"form4-05182026_080551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000206395726000001/form4-05182026_080551.xml","form_type":"4"}},{"id":774969,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":20583,"kind":"person","name":"Graf R. Mark","position":1,"cik":"0001494757","reported_name":"Graf R. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T20:18:03.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0001494757-26-000002","document":"form4-05182026_080559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494757/000149475726000002/form4-05182026_080559.xml","form_type":"4"}},{"id":774244,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46296,"kind":"person","name":"Sabater Juan A.","position":1,"cik":"0001821210","reported_name":"Sabater Juan A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T20:17:00.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0001821210-26-000002","document":"form4-05182026_080557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182121026000002/form4-05182026_080557.xml","form_type":"4"}},{"id":774296,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T20:15:54.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0001659085-26-000002","document":"form4-05182026_080548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659085/000165908526000002/form4-05182026_080548.xml","form_type":"4"}},{"id":774277,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46304,"kind":"person","name":"Szyper Linda M","position":1,"cik":"0001739050","reported_name":"Szyper Linda M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T16:19:48.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0001739050-26-000001","document":"form4-05182026_080544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739050/000173905026000001/form4-05182026_080544.xml","form_type":"4"}},{"id":775375,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":775374,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8882,"price":31.83,"value":282714.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":24115,"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":775373,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T16:14:12.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":32997,"source":{"system":"sec-edgar","filing":"0002009762-26-000004","document":"form4-05182026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000004/form4-05182026_080508.xml","form_type":"4"}},{"id":774262,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46298,"kind":"person","name":"Reicin Glenn","position":1,"cik":"0001790218","reported_name":"Reicin Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2026-05-18T16:13:05.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":164309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on April 14, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":164309,"derivative":{"exercise_price":29.29,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":164309},"source":{"system":"sec-edgar","filing":"0001790218-26-000005","document":"form4-05182026_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790218/000179021826000005/form4-05182026_080501.xml","form_type":"4"}},{"id":811012,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-09T20:15:13.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0002064712-26-000004","document":"form4-04092026_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000206471226000004/form4-04092026_040401.xml","form_type":"4"}},{"id":811011,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-09T20:15:13.000Z","date":"2026-04-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3173,"price":27.62,"value":87638.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date"}],"balance_after":4327,"source":{"system":"sec-edgar","filing":"0002064712-26-000004","document":"form4-04092026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000206471226000004/form4-04092026_040401.xml","form_type":"4"}},{"id":811010,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-09T20:15:13.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0002064712-26-000004","document":"form4-04092026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000206471226000004/form4-04092026_040401.xml","form_type":"4"}},{"id":814563,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53608,"kind":"person","name":"Anastasiou Peter","position":1,"cik":"0001999888","reported_name":"Anastasiou Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option","published_at":"2026-04-06T20:16:02.000Z","date":"2026-04-02","kind":"grant","planned":false,"acquired":true,"shares":212241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on April 2, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":212241,"derivative":{"exercise_price":27.74,"expiration_date":"2036-04-02","underlying":"Common Stock","underlying_shares":212241},"source":{"system":"sec-edgar","filing":"0001999888-26-000002","document":"form4-04062026_080458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999888/000199988826000002/form4-04062026_080458.xml","form_type":"4"}},{"id":814217,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":35187,"kind":"person","name":"Ignelzi Troy A.","position":1,"cik":"0001579829","reported_name":"Ignelzi Troy A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-04-06T20:14:04.000Z","date":"2026-04-02","kind":"grant","planned":false,"acquired":true,"shares":17710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 36 equal monthly installments beginning on May 2, 2026."}],"balance_after":17710,"derivative":{"exercise_price":27.74,"expiration_date":"2036-04-02","underlying":"Common Stock","underlying_shares":17710},"source":{"system":"sec-edgar","filing":"0001579829-26-000003","document":"form4-04062026_080459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579829/000157982926000003/form4-04062026_080459.xml","form_type":"4"}},{"id":928747,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-29T01:19:26.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":3746,"price":37.152,"value":139171.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing."}],"balance_after":24521,"source":{"system":"sec-edgar","filing":"0001677141-26-000004","document":"form4-01292026_010123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000004/form4-01292026_010123.xml","form_type":"4"}},{"id":931008,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":4725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":14175,"derivative":{"underlying":"Common Stock","underlying_shares":4725},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931007,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7625,"derivative":{"underlying":"Common Stock","underlying_shares":3813},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931006,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931005,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931004,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2553,"price":36.82,"value":94001.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":2172,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931003,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":4725,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4725,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931002,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":36.82,"value":82439.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1574,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":931001,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:49:02.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3813,"source":{"system":"sec-edgar","filing":"0001677141-26-000002","document":"form4-01262026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000002/form4-01262026_090157.xml","form_type":"4"}},{"id":930952,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7800,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930951,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930950,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930949,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930948,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1126,"price":36.82,"value":41459.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1474,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930947,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2600,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930946,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1116,"price":36.82,"value":41091.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1384,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930945,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930943,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:44:30.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":16200,"derivative":{"underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0002064712-26-000002","document":"form4-01262026_090126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000206471226000002/form4-01262026_090126.xml","form_type":"4"}},{"id":930942,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T21:44:30.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":56900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":56900,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":56900},"source":{"system":"sec-edgar","filing":"0002064712-26-000002","document":"form4-01262026_090126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000206471226000002/form4-01262026_090126.xml","form_type":"4"}},{"id":931280,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7988,"derivative":{"underlying":"Common Stock","underlying_shares":2662},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931279,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":4175,"derivative":{"underlying":"Common Stock","underlying_shares":2188},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931278,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931277,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931276,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1372,"price":36.82,"value":50517.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1290,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931275,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2662,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931274,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":36.82,"value":42453.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1035,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931273,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T16:45:37.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2188,"source":{"system":"sec-edgar","filing":"0002009762-26-000002","document":"form4-01262026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000200976226000002/form4-01262026_090132.xml","form_type":"4"}},{"id":931020,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":39000,"derivative":{"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931019,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931018,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":52900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":52900,"derivative":{"underlying":"Common Stock","underlying_shares":52900},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931017,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":184600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":184600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":184600},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931016,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":5654,"price":36.82,"value":208180.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":7346,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931015,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931014,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":4785,"price":36.82,"value":176183.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":5715,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931013,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":935004,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-21T01:39:14.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":20961,"price":35.9159,"value":752833.1799,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-26-000001","document":"form4-01212026_010111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714126000001/form4-01212026_010111.xml","form_type":"4"}},{"id":964351,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on November 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964350,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":5933,"price":40.1073,"value":237956.6109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964349,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":40.1073,"value":802146.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964348,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.22,"value":164400.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":975513,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023."}],"balance_after":185000,"derivative":{"exercise_price":29.03,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":975512,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":39.5448,"value":790896.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":975511,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:06.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":29.03,"value":580600.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001677141-25-000008","document":"form4-12092025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000008/form4-12092025_041201.xml","form_type":"4"}},{"id":988347,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-25T21:10:07.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":3427,"price":35,"value":119945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001677141-25-000006","document":"form4-11252025_041102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000006/form4-11252025_041102.xml","form_type":"4"}},{"id":1026470,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1026469,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":24039,"price":27.56,"value":662514.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":20961,"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1026468,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:07.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001677141-25-000004","document":"form4-10022025_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000167714125000004/form4-10022025_041003.xml","form_type":"4"}},{"id":1051410,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":75909,"kind":"organization","name":"Valor IV Pharma Holdings, LLC","position":1,"cik":"0001821186","reported_name":"Valor IV Pharma Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68707,"kind":"organization","name":"Valor Management L.P.","position":2,"cik":"0001822428","reported_name":"Valor Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68679,"kind":"organization","name":"Valor Equity Capital IV LLC","position":3,"cik":"0001821936","reported_name":"Valor Equity Capital IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68678,"kind":"organization","name":"Valor Equity Associates IV L.P.","position":4,"cik":"0001822427","reported_name":"Valor Equity Associates IV L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68675,"kind":"organization","name":"VALOR EQUITY PARTNERS IV L.P.","position":5,"cik":"0001705506","reported_name":"VALOR EQUITY PARTNERS IV L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68676,"kind":"organization","name":"VALOR EQUITY PARTNERS IV-A L.P.","position":6,"cik":"0001705542","reported_name":"VALOR EQUITY PARTNERS IV-A L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68677,"kind":"organization","name":"VALOR EQUITY PARTNERS IV-B L.P.","position":7,"cik":"0001705512","reported_name":"VALOR EQUITY PARTNERS IV-B L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10690,"kind":"person","name":"Gracias Antonio J.","position":8,"cik":"0001495158","reported_name":"Gracias Antonio J.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46296,"kind":"person","name":"Sabater Juan A.","position":9,"cik":"0001821210","reported_name":"Sabater Juan A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-02T21:45:59.000Z","date":"2025-08-28","kind":"other","planned":false,"acquired":false,"shares":6618033,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-25-083535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495158/000121390025083535/ownership.xml","form_type":"4"}},{"id":1061127,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":45109,"kind":"person","name":"Kapadia Sandip","position":1,"cik":"0001677141","reported_name":"Kapadia Sandip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T20:15:07.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":21573,"price":36.4983,"value":787377.8259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.87. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-022294","document":"form4-08192025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677141/000141588925022294/form4-08192025_040801.xml","form_type":"4"}},{"id":1144650,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46296,"kind":"person","name":"Sabater Juan A.","position":1,"cik":"0001821210","reported_name":"Sabater Juan A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:05:59.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013411","document":"form4-05162025_080555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925013411/form4-05162025_080555.xml","form_type":"4"}},{"id":1145314,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":10690,"kind":"person","name":"Gracias Antonio J.","position":1,"cik":"0001495158","reported_name":"Gracias Antonio J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:05:30.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013409","document":"form4-05162025_080525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495158/000141588925013409/form4-05162025_080525.xml","form_type":"4"}},{"id":1145862,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:04:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013405","document":"form4-05162025_080525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000141588925013405/form4-05162025_080525.xml","form_type":"4"}},{"id":1145729,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53608,"kind":"person","name":"Anastasiou Peter","position":1,"cik":"0001999888","reported_name":"Anastasiou Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:02:37.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013401","document":"form4-05162025_080533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999888/000141588925013401/form4-05162025_080533.xml","form_type":"4"}},{"id":1145313,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":20583,"kind":"person","name":"Graf R. Mark","position":1,"cik":"0001494757","reported_name":"Graf R. Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:01:56.000Z","date":"2025-05-25","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013399","document":"form4-05162025_080552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494757/000141588925013399/form4-05162025_080552.xml","form_type":"4"}},{"id":1144730,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:01:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013397","document":"form4-05162025_080517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659085/000141588925013397/form4-05162025_080517.xml","form_type":"4"}},{"id":1144690,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46304,"kind":"person","name":"Szyper Linda M","position":1,"cik":"0001739050","reported_name":"Szyper Linda M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T16:03:18.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013403","document":"form4-05162025_080514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739050/000141588925013403/form4-05162025_080514.xml","form_type":"4"}},{"id":1153960,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1153959,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8869,"price":29.86,"value":264828.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":9881,"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1153958,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":46516,"kind":"person","name":"Budur Kumar","position":1,"cik":"0002009762","reported_name":"Budur Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-09T16:07:59.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001415889-25-012477","document":"form4-05092025_080555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009762/000141588925012477/form4-05092025_080555.xml","form_type":"4"}},{"id":1170783,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-16T20:06:51.000Z","date":"2025-04-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-010798","document":"form4-04162025_080447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925010798/form4-04162025_080447.xml","form_type":"4"}},{"id":1170782,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":53035,"kind":"person","name":"Zaeske Adam H.","position":1,"cik":"0002064712","reported_name":"Zaeske Adam H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option","published_at":"2025-04-16T20:06:51.000Z","date":"2025-04-07","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on April 7, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":28.4,"expiration_date":"2035-04-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-010798","document":"form4-04162025_080447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925010798/form4-04162025_080447.xml","form_type":"4"}},{"id":1177833,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-04-04T21:52:34.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":14077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 36 equal monthly installments beginning on May 2, 2025."}],"balance_after":14077,"derivative":{"exercise_price":32.53,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":14077},"source":{"system":"sec-edgar","filing":"0001415889-25-010247","document":"form4-04042025_090430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000141588925010247/form4-04042025_090430.xml","form_type":"4"}}],"next_cursor":"2025-04-04T21:52:34.000000Z,1177833"}